Lvir is a brand name for a combination antiviral medication used in the treatment of chronic Hepatitis C virus (HCV) infection. It is marketed by Mylan Pharmaceuticals Pvt Ltd and is available in India under the brand name MyHep LVIR.
Category | Anticancer medication |
Brand | Mylan |
Ingredient | Ledipasvir |
Prescription Required | Yes |
Strength | 400mg |
Package | 28 Tablets |
Lvir 400mg by Mylan is a combination medication used to treat chronic Hepatitis C virus (HCV) infection. It contains two active ingredients: Ledipasvir (90 mg) and Sofosbuvir (400 mg), which work together to block different stages of the HCV replication process. Ledipasvir is an NS5A inhibitor, which interferes with the NS5A protein necessary for the virus to replicate and assemble new viral particles.
Lvir 400mg offers significant benefits for individuals with chronic Hepatitis C virus (HCV) infection. The combination of Ledipasvir and Sofosbuvir works synergistically to effectively block two critical steps in the virus’s replication cycle, resulting in a high cure rate—often exceeding 90%. One of the key advantages of Lvir is its ability to treat a wide range of HCV genotypes, making it a versatile option for many patients.
Lvir 400mg (Ledipasvir and Sofosbuvir) should not be taken by individuals who are allergic to any of the components of the medication. It is also contraindicated for pregnant women when used with ribavirin, as ribavirin can cause serious birth defects. Lvir 400mg should not be used by those with severe kidney impairment or end-stage renal disease unless closely monitored by a healthcare provider, as the medication is primarily processed by the kidneys.
Lvir 400mg (Ledipasvir and Sofosbuvir) should be taken exactly as prescribed by your healthcare provider. The usual dosage is one tablet (400 mg Sofosbuvir and 90 mg Ledipasvir) taken once daily, with or without food. It’s important to take the tablet at the same time each day to help you remember and maintain consistent levels of the medication in your body.
There are no reviews yet.